These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effect of inhibition of polyamine biosynthesis on the growth and telomerase activity of human laryngeal carcinoma cells Hep-2].
    Author: Li Y, Fan M, Cao S, Zhang X.
    Journal: Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):261-3. PubMed ID: 12761991.
    Abstract:
    OBJECTIVE: To observe the effect of difluoromethylornithine (DFMO), an inhibitor of polyamine biosynthesis, on the growth and telomerase activity of human laryngeal carcinoma cells Hep-2, and try to find a new clue to search for the mechanism of reversion of tumor malignant phenotype via polyamine biosynthesis inhibition. METHODS: The growth characteristics of Hep-2 cells treated with DFMO were studied by morphological observation, cell growth curve and FCM analysis. Telomerase activity was detected by Telomerase Repeat Amplification Protocol (TRAP). RESULTS: The inhibition of cell proliferation, a marked increase in G1 and a decrease in S phase populations in the cell cycle of 2.5 mmol/L or 5 mmol/L DFMO treated Hep-2 cells were demonstrated; The cell apoptosis was shown by cell morphology and apoptosis peak in FCM; The telomerase activity of the treated cells was suppressed, while these changes were prevented by provision of exogenous putrescine(Pu) along with DFMO. CONCLUSION: Inhibition of polyamine biosynthesis could result in the proliferation inhibition and apoptosis induction of Hep-2 cells, which was associated with suppressed telomerase activity. It is suggested that inactivation of telomerase would be one of the important molecular events in reversion of tumor malignant phenotype via inhibition of polyamine biosynthesis.
    [Abstract] [Full Text] [Related] [New Search]